This inventor holds 1 USPTO granted patent. Top assignee: Novaliq Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bernhard Hauptmeier: Innovator in Pharmaceutical Compositions
Introduction
Bernhard Hauptmeier is a notable inventor based in Schriesheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize timolol, a beta 1 (β)-receptor blocker. His work is essential in addressing various ocular conditions.
Latest Patents
Hauptmeier holds a patent for a pharmaceutical composition comprising timolol and a liquid vehicle made of a semifluorinated alkane. This innovative formulation is designed for topical administration, specifically for ophthalmic use. It is particularly beneficial in the treatment of glaucoma, increased intraocular pressure, and ocular hypertension.
Career Highlights
Bernhard Hauptmeier is associated with Novaliq GmbH, a company that focuses on developing innovative therapies for ocular diseases. His expertise in pharmaceutical compositions has positioned him as a key player in the industry. Hauptmeier's patent reflects his commitment to improving patient outcomes through advanced medical solutions.
Collaborations
He has collaborated with notable colleagues, including Frank Löscher and Sonja Krösser, who share a dedication to advancing pharmaceutical research and development.
Conclusion
Bernhard Hauptmeier's contributions to pharmaceutical innovations, particularly in the area of ocular treatments, highlight his role as a significant inventor in the field. His work continues to impact the lives of patients suffering from various eye conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile